Ashley Kalinauskas is the founder and CEO of Torigen, a biotechnology company helping our furry best friends live longer, healthier lives. Their initial product is a personalized cancer vaccine that was originally developed to move forward for human clinical studies, but was repositioned to help the millions of dogs, cats and horses after a cancer diagnosis. Ashley has grown the company from an idea on the scientific benchtop, to a company raising over $25M and poised to help grow the animal health industry. Ashley has been named to Forbes 30 under 30, Connecticut Entrepreneur of the Year and currently serves on multiple boards and advisory committees advancing innovation within universities and with startup animal health companies.
